Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
51.35
-8.23 (-13.81%)
At close: Aug 15, 2025, 4:00 PM
59.31
+7.96 (15.50%)
After-hours: Aug 15, 2025, 7:59 PM EDT
TNXP Market Cap
TNXP has a market cap or net worth of $449.06 million as of August 15, 2025. Its market cap has increased by 4,176.95% in one year.
Market Cap
449.06M
Enterprise Value
324.23M
1-Year Change
4,176.95%
Ranking
Category
Stock Price
$51.35
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $449.06M, an increase of 6,056.91%. That is a compound annual growth rate of 96.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 449.06M | 628.56% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | 129.17M | 1,226.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 240.81B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |